Key take-aways and insights from Yong Tai Bhd (7066) Executiv | Rakuten Trade Ideas 🎯

Key take-aways and insights from Yong Tai Bhd (7066) Executive Director/CEO Datuk Wira Boo Kuang Loon on Rakuten Trade Ideas Webinar last nite

- SZKT Covid-19 vaccine Phase 3 clinical trial started with initial 3,000 doses (given free by SZKT) having near full registration
- Yong Tai healthcare unit has insurance coverage for the volunteers who participate in the Phase 3 clinical trial studies
-expect to obtain final approval by September on the result of clinical trial where there are allocation from SZKT for 10m doses
-SZKT expressed interest to set up production facilities in Malaysia and R&D center for other vaccines too
-appointed in March to undertake gold mining project in Lipis, Pahang with encouraging results and to commence production by Aug with estimated 20kg of gold monthly
-management focusing on 2 main growth driver, vaccine rollout and gold mining to support their tourism related business and property segment which are impacted by the pandemic

Yong Tai Bhd (7066) 执行董事兼首席执行官Datuk Wira Boo Kuang Loon昨晚在Rakuten Trade Ideas 网络研讨会的主要见解。

- SZKT Covid-19 疫苗 第3 期临床试验即将开始，初始 3,000 剂（由 SZKT 免费提供）已接近完全注册
- 永大医疗保健单位有为参与第三期临床试验研究的志愿者提供保险
- 预计在9月之前获得临床试验结果的最终批准，其中SZKT即将分配10m剂疫苗给永大
-SZKT表示有兴趣在马来西亚设立生产设施和其他疫苗的研发中心
- 在3月时获委任在彭亨州进行金矿项目。这项目将于8月开始投入生产，估计每月可开采20公斤黄金
- 管理层专注于 2 个主要增长动力：疫苗推出和金矿开采，以支持受疫情影响的旅游相关业务和房地产业务